The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

73 articles for H Cho


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.EBI
Seoul National University
Identification of the First Selective Activin Receptor-Like Kinase 1 Inhibitor, a Reversible Version of L-783277.EBI
Korea University
Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity.EBI
Suntory Institute For Biomedical Research
N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.EBI
Seoul National University
N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity.EBI
Seoul National University
Synthesis of N,N',N"-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor.EBI
Seoul National University
Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.EBI
Ewha Womans University
Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities.EBI
Korea University of Science and Technology
A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants.EBI
Korea Institute of Science & Technology (Kist)
Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).EBI
Korea University of Science and Technology (Ust)
Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase.EBI
Mcgill University
Cell-based biological evaluations of 5-(3-bromo-4-phenethoxybenzylidene)thiazolidine-2,4-dione as promising wound healing agent.EBI
Chosun University
Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.EBI
Yonsei University
Sulfonamides as multifunctional agents for Alzheimer's disease.EBI
University of Massachusetts Boston
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.EBI
Korea Research Institute of Chemical Technology
Control of the intracellular levels of prostaglandin E2 through inhibition of the 15-hydroxyprostaglandin dehydrogenase for wound healing.EBI
Chungbuk National University
Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity.EBI
Korea Institute of Science and Technology
3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).EBI
Kyung Hee University
Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.EBI
Sk Biopharmaceuticals
Inhibition of IKK-beta: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32.EBI
Inha University
Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors.EBI
Chosun University
Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.EBI
Sejong University
2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity.EBI
Inha University
Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity.EBI
Inha University
Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.EBI
Central Pharmaceutical Research Institute
Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors.EBI
Central Pharmaceutical Research Institute
Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.EBI
Central Pharmaceutical Research Institute
Evans Blue and other dyes as protein tyrosine phosphatase inhibitors.EBI
Inha University
Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors.EBI
University of Illinois At Chicago
Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-¿ activators.EBI
Inha University
Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.EBI
Chosun University
Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 production.EBI
Seoul National University
Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.EBI
Yangji Chemicals
Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.EBI
Inha University
Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.EBI
Sejong University
Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.EBI
Inha University
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors.EBI
Korea University
Discovery of N-(5-amido-2-methylphenyl)-5-methylisoxazole-3-carboxamide as dual CSF-1R/c-Kit Inhibitors with improved stability and BBB permeability.EBI
Hanyang University
Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs.EBI
Inha University
Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases.EBI
Hanyang University
Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease.EBI
Hanyang University
PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta).EBI
Inha University
Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer's Disease: In Vivo Studies on Mouse Models.EBI
Hanyang University
Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.EBI
Korea Research Institute of Chemical Technology
Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligands.EBI
Seoul National University
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology.EBI
Quantitative Biosciences
Identification of Thieno[3,2-EBI
Yonsei University College of Medicine
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-4H-thieno[3,2-b]azepine derivatives: novel arginine vasopressin antagonists.EBI
Central Pharmaceutical Research Institute
Formylchromone derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors.EBI
Inha University
A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity.EBI
Gwangju Institute of Science and Technology
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.EBI
Merck
Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors.EBI
Korea University
Identification of a Unique Resorcylic Acid Lactone Derivative That Targets Both Lymphangiogenesis and Angiogenesis.EBI
Korea University
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.EBI
Seoul National University
First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia.EBI
Korea University
Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.EBI
Institute For Bio-Medical Research
SARS-CoV-2 inhibitors for treating coronavirus infectionsBDB
Insilico Medicine Ip
Combination therapy for treatment of hematological diseasesBDB
Incyte
Aza-indazole compounds for use in tendon and/or ligament injuriesBDB
Novartis
2-(morpholin-4-yl)-1,7-naphthyridinesBDB
Bayer Pharma Aktiengesellschaft
Selective NR2B antagonistsBDB
Bristol-Myers Squibb
Tricyclic heterocyclic compoundsBDB
Bristol-Myers Squibb
Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.BDB
The Royal Danish School of Pharmacy
Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant.BDB
Janssen Research Foundation
Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.BDB
Bryn Mawr College
Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities.BDB
Hong Kong University of Science and Technology
2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors.BDB
Merck Sharp and Dohme Research Laboratories
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor.BDB
Parke-Davis Pharmaceutical Research